pharma news today obesity drugs glp-1 today Drug Market: the rapid growth of the diabetes and market What is the pipeline for
Description
doi: 10.3389/fimmu.2019.01223
Radiolabel studies suggest small peptides like exenatide and lixisenatide cross the BBB, while acylated or PEGylated analogues (liraglutide, semaglutide, NLY01) show minimal uptake
PD clinical trials The neuroprotective effects of GLP-1RAs, particularly exenatide, seem to be more promising in PD
Although these three types of cells each have distinct functions, it is more important to note that the somatostatin, glucagon, and insulin they secrete work together through mutual regulation and feedback mechanisms to maintain blood glucose balance and overall metabolic homeostasis
Further, experimental data suggest that the pro-survival action of GLP-1RAs may also be mediated by the Akt-dependent stimulation of the mTORC1/S6K1 pathway, the activation of which is dependent upon the IGF-1R, as observed in rodent islet cells (44)
[DOI] [PubMed] [Google Scholar] 56.Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV, et al
